These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23658149)

  • 1. Mir-142-3p target sequences reduce transgene-directed immunogenicity following intramuscular adeno-associated virus 1 vector-mediated gene delivery.
    Majowicz A; Maczuga P; Kwikkers KL; van der Marel S; van Logtenstein R; Petry H; van Deventer SJ; Konstantinova P; Ferreira V
    J Gene Med; 2013; 15(6-7):219-32. PubMed ID: 23658149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circumventing cellular immunity by miR142-mediated regulation sufficiently supports rAAV-delivered OVA expression without activating humoral immunity.
    Xiao Y; Muhuri M; Li S; Qin W; Xu G; Luo L; Li J; Letizia AJ; Wang SK; Chan YK; Wang C; Fuchs SP; Wang D; Su Q; Nahid MA; Church GM; Farzan M; Yang L; Wei Y; Desrosiers RC; Mueller C; Tai PW; Gao G
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31112525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel Combinatorial MicroRNA-Binding Sites in AAV Vectors Synergistically Diminish Antigen Presentation and Transgene Immunity for Efficient and Stable Transduction.
    Muhuri M; Zhan W; Maeda Y; Li J; Lotun A; Chen J; Sylvia K; Dasgupta I; Arjomandnejad M; Nixon T; Keeler AM; Manokaran S; He R; Su Q; Tai PWL; Gao G
    Front Immunol; 2021; 12():674242. PubMed ID: 33995418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibits transgene expression in the liver.
    Qiao C; Yuan Z; Li J; He B; Zheng H; Mayer C; Li J; Xiao X
    Gene Ther; 2011 Apr; 18(4):403-10. PubMed ID: 21150938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of immunity to antigens expressed by recombinant adeno-associated virus depends on the route of administration.
    Brockstedt DG; Podsakoff GM; Fong L; Kurtzman G; Mueller-Ruchholtz W; Engleman EG
    Clin Immunol; 1999 Jul; 92(1):67-75. PubMed ID: 10413654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged gene expression in muscle is achieved without active immune tolerance using microrRNA 142.3p-regulated rAAV gene transfer.
    Boisgerault F; Gross DA; Ferrand M; Poupiot J; Darocha S; Richard I; Galy A
    Hum Gene Ther; 2013 Apr; 24(4):393-405. PubMed ID: 23427817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral-tolerization Prevents Immune Responses and Improves Transgene Persistence Following Gene Transfer Mediated by Adeno-associated Viral Vector.
    Hardet R; Chevalier B; Dupaty L; Naïmi Y; Riou G; Drouot L; Jean L; Salvetti A; Boyer O; Adriouch S
    Mol Ther; 2016 Feb; 24(1):87-95. PubMed ID: 26265250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to intramuscular administration of alipogene tiparvovec (AAV1-LPL(S447X)) in a phase II clinical trial of lipoprotein lipase deficiency gene therapy.
    Ferreira V; Twisk J; Kwikkers K; Aronica E; Brisson D; Methot J; Petry H; Gaudet D
    Hum Gene Ther; 2014 Mar; 25(3):180-8. PubMed ID: 24299335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic protein delivery by muscle-gene transfer is limited by a local immune response.
    Wang L; Dobrzynski E; Schlachterman A; Cao O; Herzog RW
    Blood; 2005 Jun; 105(11):4226-34. PubMed ID: 15713796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates.
    Le Guiner C; Stieger K; Toromanoff A; Guilbaud M; Mendes-Madeira A; Devaux M; Guigand L; Cherel Y; Moullier P; Rolling F; Adjali O
    PLoS One; 2014; 9(9):e102538. PubMed ID: 25248159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of viral dose on neutralizing antibody response and transgene expression after AAV1 vector re-administration in mice.
    Petry H; Brooks A; Orme A; Wang P; Liu P; Xie J; Kretschmer P; Qian HS; Hermiston TW; Harkins RN
    Gene Ther; 2008 Jan; 15(1):54-60. PubMed ID: 17960164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.
    Sarukhan A; Camugli S; Gjata B; von Boehmer H; Danos O; Jooss K
    J Virol; 2001 Jan; 75(1):269-77. PubMed ID: 11119597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle-Directed Delivery of an AAV1 Vector Leads to Capsid-Specific T Cell Exhaustion in Nonhuman Primates and Humans.
    Gernoux G; Gruntman AM; Blackwood M; Zieger M; Flotte TR; Mueller C
    Mol Ther; 2020 Mar; 28(3):747-757. PubMed ID: 31982038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscle.
    Subang MC; Fatah R; Wu Y; Hannaman D; Rice J; Evans CF; Chernajovsky Y; Gould D
    Curr Gene Ther; 2015; 15(1):3-14. PubMed ID: 25545919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle-specific promoters may be necessary for adeno-associated virus-mediated gene transfer in the treatment of muscular dystrophies.
    Cordier L; Gao GP; Hack AA; McNally EM; Wilson JM; Chirmule N; Sweeney HL
    Hum Gene Ther; 2001 Jan; 12(2):205-15. PubMed ID: 11177557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle as a target for supplementary factor IX gene transfer.
    Hoffman BE; Dobrzynski E; Wang L; Hirao L; Mingozzi F; Cao O; Herzog RW
    Hum Gene Ther; 2007 Jul; 18(7):603-13. PubMed ID: 17594244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-restricted transgene expression in the retina.
    Karali M; Manfredi A; Puppo A; Marrocco E; Gargiulo A; Allocca M; Corte MD; Rossi S; Giunti M; Bacci ML; Simonelli F; Surace EM; Banfi S; Auricchio A
    PLoS One; 2011; 6(7):e22166. PubMed ID: 21818300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of T-Cell Infiltration and Programmed Death Ligand 2 Expression by Adeno-Associated Virus in Rhesus Macaque Skeletal Muscle and Modulation by Prednisone.
    Cramer ML; Shao G; Rodino-Klapac LR; Chicoine LG; Martin PT
    Hum Gene Ther; 2017 Jun; 28(6):493-509. PubMed ID: 28345428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant adeno-associated virus for muscle directed gene therapy.
    Fisher KJ; Jooss K; Alston J; Yang Y; Haecker SE; High K; Pathak R; Raper SE; Wilson JM
    Nat Med; 1997 Mar; 3(3):306-12. PubMed ID: 9055858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses to adeno-associated virus vectors.
    Zaiss AK; Muruve DA
    Curr Gene Ther; 2005 Jun; 5(3):323-31. PubMed ID: 15975009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.